Bd surpasses scope 1 and 2 reduction milestones for fy 2023

Franklin lakes, n.j. , july 10, 2024  /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced it has surpassed its scope 1 and 2 science-based greenhouse gas (ghg) emissions reduction targets for fy 2023 by 5 percentage points and received approval for near and long-term science-based emissions reduction targets from the science based target initiative (sbti)[1].
BDX Ratings Summary
BDX Quant Ranking